| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.036 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |